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Abstract
The diagnosis and assessment of urinary incontinence (UI) are variable. In general, diag-
nosis is made in primary care using clinical evaluation (a good history and physical 
examination), bladder diary and validated symptom scales. Condition-specific diagnosis 
is made in secondary care, and it often involves interventional tools such as urodynamic 
studies. The evidence available on the accuracy and acceptability of the assessment of UI is 
inconsistent and variable. A structured data collection tool was used for initial assessment 
of UI. Some key questions are required for initial assessment of UI in order to diagnose 
the type of UI. This chapter includes a gender-specific evaluation based on history and 
clinical examination. Pelvic organ prolapse (POP) in female patients is associated with UI 
and POP diagnosis, and staging is made by clinical examination only, while male patients 
are examined for prostate obstructive urinary symptoms. Basic evaluation includes blad-
der diary in cases of overactive bladder and stress test, for stress urinary incontinence. 
Other diagnostic tests include urine analysis, uroflowmetry and measurement of post-
void residual volume in cases of neurogenic bladder and benign prostate hypertrophy. 
Patients referred to specialist require further assessment of UI using urodynamic testing, 
electrophysiological test and imaging.
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1. Introduction
Urinary incontinence (UI), the involuntary leakage of urine, often remains undetected and 
undertreated [1]. Estimates of prevalence vary depending on the population studied and the 
instruments used to assess severity. The prevalence of UI increases with age. Women are gen-
erally reluctant to initiate discussions about their incontinence and urinary symptoms due to 
embarrassment, lack of knowledge about treatment options and/or fear of surgery.
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The objectives of initial assessment are to establish a presumptive or disease-specific diag-
nosis by excluding other conditions that mimic UI. The treatment is offered according to the 
level of bother and impact of UI on patient’s quality of life (QoL). A detailed assessment is 
required to initiate initial treatment or to plan complex testing, which may require specialist 
referral. It also aids in the assessment of the level of improvement after any intervention from 
information obtained from patient or care providers.
A critical step in the evaluation of urinary incontinence is the use of up-to-date terminology 
to describe different types of UI and their associated lower urinary tract symptoms (LUTS). 
LUTS includes both storage and emptying symptoms in distinction to overactive bladder syn-
drome (OAB) that describes the subset of storage symptoms urgency, frequency and nocturia 
with or without the symptoms of UI.
The terminology defined below is adopted from a review available from the 5th International 
Consultation on Incontinence [2]. The use of standardized terminology during the taking of 
the history of the types of UI ensures uniformity in the assessment of symptoms that lead to 
diagnose various types of UI.
Male LUTS are a frequently encountered constellation of symptoms that consist of both stor-
age and emptying functions of the lower tract. The index male patient with LUTS is either an 
elderly male with bothersome dysfunction of storage, voiding and/or the post-micturition 
period that often consists of a combination of frequency, urgency, nocturia, as well as hesi-
tancy, weak stream and feeling of incomplete emptying. The other index male patient is a 
young male with mostly storage symptoms and sometimes voiding as well.
2. Terminology
Stress urinary incontinence (SUI) is referred to as involuntary urinary loss of effort or physical 
exertion, e.g. sporting activities or of sneezing or coughing.
Urgency urinary incontinence (UUI) is a condition referred to as involuntary loss of urine 
associated with a desire to void.
Postural urinary incontinence is a condition of involuntary loss of urine associated with 
change of body position, e.g. rising from a seated or lying position.
Mixed urinary incontinence (MUI) is the complaint of involuntary loss of urine associated 
with urgency and also with exertion, effort, sneezing or coughing.
Incontinence associated with chronic retention of urine is defined as a complaint of involun-
tary loss of urine, which occurs in conditions where the bladder does not empty completely as 
indicated by a significantly high residual urine volume and/or a non-painful bladder, which 
remains palpable or percussable after the individual has passed urine. (Note: The International 
Continence Society (ICS) no longer recommends the term overflow incontinence. A significant 
residual urine volume denotes a minimum volume of 300 mL, although this figure has not 
been well established).
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Nocturnal enuresis: Complaint of involuntary loss of urine that occurs during sleep.
Continuous (urinary) incontinence: Complaint of constant involuntary loss of urine.
Insensible (urinary) incontinence: Complaint of urinary incontinence where the individual is 
unaware of how it occurred, the first sensation of which is a feeling of being wet.
Coital incontinence (for women only): Complaint of involuntary loss of urine with coitus. 
This symptom can be further divided into that occurring with penetration or intromission 
and that occurring at orgasm.
Functional incontinence: Complaint of involuntary loss of urine that results from an inability 
to reach the toilet due to cognitive, functional or mobility impairments in the presence of an 
intact lower urinary tract system.
Post-prostatectomy incontinence (PPI) generally is used for stress urinary incontinence fol-
lowing radical prostatectomy for prostate cancer. However, the term is also used for post-
transurethral prostatectomy for benign prostate hypertrophy (BPH). Although small degrees 
of incidental incontinence may go virtually unnoticed, larger degrees of incontinence can 
have a major impact on a man’s quality of life.
2.1. Bladder storage symptoms
Bladder storage symptoms are experienced during the bladder filling.
Increased daytime urinary frequency: Complaint that micturition occurs more frequently 
during waking hours than previously deemed normal. Traditionally, seven episodes of mic-
turition during waking hours were considered as the upper limit of normal, although it may 
be higher in some populations.
Nocturia: Complaint of interruption of sleep one or more times because of the need to void. 
Each void is preceded and followed by sleep. (Note: The number of nocturia episodes and the 
degree of bother based on number have been questioned and the threshold of 2–3 per night 
has been suggested.) [3–5].
Urgency: Complaint of a sudden, compelling desire to pass urine, which is difficult to defer 
(Note: The ‘all or none’ nature of ‘urgency’ has been questioned.) [6].
Overactive bladder syndrome (OAB): Urinary urgency, usually accompanied by increased 
urinary frequency and nocturia, with or without urgency urinary incontinence, in the absence 
of urinary tract infection (UTI) or other obvious pathology.
2.2. Diagnostic evaluation
2.2.1. History and physical examination
The initial assessment includes a very good history and the use of validated questionnaire 
to know the type of urinary incontinence and its impact on patient’s quality of life (QoL). A 
detailed history enables to diagnose complicated cases of UI-like UI associated with pelvic 
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organ prolapse (POP), MUI, neurogenic bladder dysfunction and continuous UI secondary to 
diverticulum or fistula.
A good history should also identify patients who need rapid referral to an appropriate spe-
cialist. These include patients with associated pain, haematuria, history of recurrent urinary 
tract infection (UTI), pelvic surgery (particularly pelvic organ prolapse surgery) and UI asso-
ciated with known abnormality of the urinary tract. Women with obstetric history including 
complicated labour followed by continuous UI are suggestive of a fistula. A detailed gyn-
aecological history may help to understand the underlying cause, for example, polycystic 
ovarian disease and associated insulin resistance leading to UI among women of younger 
age group [7].
The medical history should include history of smoking and chronic cough, chronic obstruc-
tive pulmonary disease (COPD), congestive heart failure and diabetes. A poor glycaemic con-
trol and medication for cardiac disease are associated with UI.
Use of questionnaires may facilitate disclosure of embarrassing symptoms, ensure that symp-
toms are not omitted and standardize information for audit and research. In the absence of 
questionnaire use, Table 1 summarizes key questions for the initial assessment of urinary 
incontinence.
The International Modular Questionnaire (ICIQ) was developed to meet the need of a univer-
sally acceptable standard guide for the selection of questionnaires to be used in clinical prac-
tice and research [8]. Urine output is greatly dependent upon the quantity and type of fluids 
taken during the day. Patients’ record of volume and frequency of micturition provides an 
excellent record for discrimination of the physiologic influences on the pattern and frequency 
of micturition. This is called frequency volume charting. Use of additional  information like 
Do you leak urine?
If yes then do you feel the leak of urine?
If yes then does it occur with urgency and on the way to toilet? (Identify trigger factor such as key in latch.)
Do you wake up at night to void, if yes then how frequent?
If urinary leak is without sensation then questions related to neurological/cognitive deficits should be asked co-existing 
diseases (diabetes, heart disease, neurological impairment should be ruled out).
Do you leak urine when you cough, sneeze, laugh and during physical exertion? (Identify circumstances, e.g. sexual 
activity, posture change.)
Duration of the symptoms?
Frequency of leak accidents and the amount of leak.
Associated symptoms of pelvic organ prolapse (POP), fecal incontinence (FI) should be asked along with identification 
of risk factors as complicated deliveries, pelvic surgery, and chronic constipation.
Impact on personal and social life?
Episodes of urinary tract infection or haematuria?
Table 1. Key questions in the` initial assesment of urinary incontinence.
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fluid intake, use of pads, activities during recording or symptom scores constitutes the blad-
der diary. It is recommended by European Association of Urology (EAU) guidelines that 
micturition frequency volume charts (FVCs) or bladder diaries should be used to assess 
male LUTS with a prominent storage component or nocturia. It is also recommended that 
these records be performed for at least 3 days for validation. Each module provides ques-
tions related to core symptoms and impact on health-related quality of life (HRQL). ICIQ 
provides evaluation of lower urinary tract symptoms (LUTS), urinary incontinence, vagi-
nal symptoms and bowel symptoms although more extensive information can be found on 
www.iciq.net.
The International Prostate Symptom Score (IPSS) is an eight-item questionnaire, consisting 
of seven symptom questions and one quality-of-life question [9]. The IPSS score is used to 
categorize patients into four categories. This is helpful in deciding about treatment strat-
egy. The categorization is ‘asymptomatic’ (0 points), ‘mildly symptomatic’ (1–7 points), 
‘moderately symptomatic’ (8–19 points) and ‘severely symptomatic’ (20–35 points). There 
are many limitations to the use of IPSS, and these include lack of assessment of inconti-
nence, of post-micturition symptoms and of bother caused by each separate symptom. 
Another limitation is that a basic minimum education level is required for filling the form. 
An alternate to this is a use of Visual prostate symptom score (VPSS), which is visual coun-
terpart of the IPSS [10].
The International Consultation on Incontinence Questionnaire for Male LUTS (ICIQ-MLUTS) 
was created from the ICS male questionnaire. It is a widely used and validated patient com-
pleted questionnaire [11]. It contains 13 items, with subscales for nocturia and OAB, and is 
available in 17 languages [12]. The EAU guidelines recommend that a validated symptom 
score questionnaire including QoL assessment should be used during the assessment of male 
LUTS and for re-evaluation during and/or after treatment [12].
A clinical examination remains an essential part of the assessment of patients with UI. It is 
essential that all patient presented with UI should be mentally competent and be capable of 
independent toileting.
A careful abdominal examination should be performed for surgical scars, hernias, masses, 
organomegaly and distended bladder after voiding. The presence of hernias may indicate inher-
ent connective tissue weakness, a possible contributor to incontinence. Masses may contribute 
to stress incontinence and, occasionally, may cause obstructed voiding with resultant overflow 
incontinence.
Pelvic examination should be performed as a routine gynaecological examination. It begins 
with the inspection of the external genitalia and urethral meatus. Evidence of atrophy, such 
as pallor and thinness of tissue, may indicate oestrogen deficiency. A red, fleshy lesion of the 
posterior urethra, a caruncle, may be another indicator of urogenital hypoestrogenism. The 
suburethral area should be inspected and palpated. A suburethral mass should raise suspi-
cion for a urethral diverticulum. Any pelvic floor defect should be documented using pel-
vic organ prolapse (POP) grading. For standardization and uniformity in staging the degree 
of prolapse, it is recommended that pelvic organ prolapse quantification (POP-Q) method 
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should be used as shown in Figure 1 [13]. POP-Q involves measurement of both anterior and 
posterior vaginal walls and cervical prolapse with reference to hymen and defines four stages 
of POP as shown in Figure 2 [13].
2.2.2. Stress test
A cough test should be performed with comfortably full bladder in standing position and it 
may reveal SUI. Price and Noblett recently compared the accuracy of the cough stress to the 
pad test for diagnosing stress urinary incontinence [14]. The cough stress test demonstrated 
Figure 2. POP-Q staging.
Figure 1. Pelvic organ prolapse quantification.
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superiority over the pad test with a sensitivity, specificity and positive and negative predic-
tive values of 90, 80, 98 and 44%, respectively, for diagnosing stress urinary incontinence. A 
negative test is less useful because a false negative may result from a small urine volume in 
the bladder or from patient inhibition.
2.2.3. Q-tip test
This test is not routinely performed, and it was used to assess urethral hypermobility (also 
referred to as bladder neck hypermobility), present in most women who have primary SUI. 
Historically, the urethral cotton swab test (Q-tip test) was the most common test used to evalu-
ate urethral mobility; it has questionable test-retest and inter-observer reliability [15]. Studies 
have demonstrated that almost all (over 90%) women with advanced point Aa prolapse will 
have a positive cotton swab test [16]. The role of urethral hypermobility testing is currently 
limited as it is unlikely to change management.
2.2.4. Examination of prostate
Men with BPH often present with paradoxical incontinence. Paradoxical incontinence or over-
flow incontinence is a condition, which clinically presents with UI, however, these patients are in 
urinary retention. The assessment of these patients often starts with physical examination follow-
ing a careful history. The key to diagnosis is the presence of palpable bladder with prostomegaly.
Determination of prostate volume is important to give an idea about the presence of prostatic 
enlargement and its presumed aetiology for obstruction. In men with symptoms suggestive 
of BPH, an accurate estimation of the degree of prostate volume enlargement is important for 
the choice of treatment, and for prediction of the treatment effect, the risk of acute urinary 
retention and the need for surgery. Digital-rectal examination (DRE) is the simplest way to 
assess prostate volume; however, its correlation with actual volume as determined by tran-
srectal ultrasound (TRUS) is rather poor. DRE underestimates the prostate volume particu-
larly with volume >30 mL [17]. A model of visual aids has been developed to help urologists 
estimate prostate volume more accurately [18]. One study concluded that DRE was sufficient 
to discriminate between prostate volumes more or less than 50 mL [19].
2.2.5. Pelvic assessment
Pelvic floor muscle contraction should be assessed by digital posterior vaginal wall examina-
tion, and any pelvic floor muscle dysfunction should be documented using the International 
Continence Society (ICS) terminology [20].
2.2.6. Neurological examination
A detailed neurological examination is not necessary in the initial evaluation of all women 
with incontinence unless patients present with sudden onset of incontinence (especially 
urgency symptoms) or new onset of neurologic symptoms [21]. In patients where there is a 
concern for neurological disease, a limited evaluation of lower extremity strength, reflexes 
and perineal sensation is required. Unilateral weakness or hyper-reflexia of the lower extrem-
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ity may identify an upper motor lesion. Absent perineal sensation with decreased rectal tone 
is concerning for cauda equina syndrome.
2.2.7. Pad testing
Pad test is not routinely performed, and it is part of research studies only. Measurement 
of urine loss using an absorbent pad worn over a set period of time or during a protocol of 
physical exercise can be used to quantify the presence and severity of UI, and of response 
to treatment. The usefulness of pad tests in quantifying severity and predicting outcome 
of treatment is uncertain [22]. There is no evidence that one type of pad test is superior to 
another.
2.2.8. Voiding diaries
Voiding diaries include information on incontinence episodes, pad usage, fluid intake, degree 
of urgency and degree of UI. Several studies have compared patients’ preference for, and the 
accuracy of, electronic and paper voiding diaries in voiding dysfunction [23–26]. A recent 
guideline on urinary incontinence by European Association of Urology recommends that 
patients with urinary incontinence should be asked to complete a voiding diary for 3–7 days to 
evaluate co-existing storage and voiding dysfunction. It is recommended by EAU guidelines 
that micturition frequency volume charts or bladder diaries should be used to assess male 
LUTS with a prominent storage component or nocturia. It is also recommended that these 
records be performed for at least 3 days for validation [27]. The ideal duration of a diary is not 
clear; however, 5th ICI recommends 1-day frequency volume chart (FVC) which includes the 
first morning void the following day as a reasonable tool to gain insight into voiding habits 
during normal daily routine [2].
2.3. Laboratory tests
Only a few clinical tests are necessary for the initial evaluation of a woman with urinary 
incontinence, as conservative treatment can be initiated based on the symptoms alone.
A urinalysis should be performed in all patients, and urine culture performed if a urinary tract 
infection (UTI) is suggested on screening. Urinalysis (dipstick or sediment) must be included 
in the primary evaluation of any patient presenting with LUTS to identify conditions, such 
as urinary tract infections (UTI), non-visible haematuria and diabetes mellitus. Urinalysis is 
recommended in most guidelines in the primary management of patients with LUTS [28, 29]. 
There is a limited evidence, yet general expert consensus that the benefits outweigh the costs 
[30]. The value of urinary dipstick/microscopy for diagnosing UTI in men with LUTS without 
acute frequency and dysuria has recently been questioned [31].
Urine cytology is indicated in patients without UTI who have visible or non-visible haema-
turia with risk factors for malignancy (e.g. extensive smoking history). Renal function tests 
are not required unless there is a concern for severe urinary retention resulting in hydrone-
phrosis [32]. Other laboratory testing is determined by signs or symptoms elicited in history 
and physical exam.
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2.3.1. Post-void residual
Female patients who present with storage-specific symptoms, with normal sensation and no 
complaints of decreased bladder emptying, and no anatomical, neurological, organ-specific 
or co-morbid risk factors for retention may not require the measurement of PVR urine. A 
PVR should be performed when decreased bladder emptying is suspected in patients with 
neurologic disease, recurrent urinary tract infections, history concerning for detrusor under 
activity or bladder outlet obstruction (BOO), history of urinary retention, severe constipation, 
pelvic organ prolapse beyond the hymen, new onset or recurrent incontinence after surgery 
for incontinence, diabetes mellitus with peripheral neuropathy or medications that suppress 
bladder contractility or increase sphincter tone [2].
PVR is assessed by transabdominal ultrasound, bladder scan or catheterization. Jalbani and 
Ather [33] noted that the bladder scan estimate is as accurate as catheterization for determin-
ing the PVR urinary volume. Its accuracy was also comparable when the urinary volume is 
<100 mL, and there was no significant effect of age, gender and body mass index. This system 
could replace the more invasive catheterization with excellent accuracy. High PVR is either 
due to obstruction (like benign prostatic obstruction, BPO, in ageing men) or poor detru-
sor contraction (frequently seen in diabetics). Higher PVRs are reliable marker for BPO. Two 
landmark studies, i.e. medical therapy of prostate symptoms (MTOPSs) and alfuzosin long-
term efficacy and safety study (ALTESS) have assessed the impact of significant PVR and risk 
of disease progression. Both the medical therapy of prostate symptoms (MTOPSs) and alfu-
zosin long-term efficacy and safety study (ALTESS) studies showed that high baseline PVR is 
associated with increased risk of symptom progression [34, 35].
2.3.2. Role of Urodynamic
Urodynamic studies are defined as a functional study of lower urinary tract. It is an inva-
sive procedure and includes filling and voiding cystometry, pressure flow studies, urethral 
sphincter electromyography (EMG), urethral function tests/urethral pressure profilometry 
and videourodynamics (VUDS). These studies involve the use of a double- or triple-lumen 
urethral catheter to fill the bladder and record bladder and urethral pressures (need triple-
lumen catheter). Detrusor pressures are not directly measured. It is a calculated value for 
intra-bladder pressure (determined by bladder catheter) minus the intra-abdominal pressure 
(determined by rectal catheter).
It is not required in the initial evaluation of urinary incontinence in women whose symptoms 
are consistent with stress, urgency or mixed, incontinence [36]. A 2013 systematic review of 99 
studies including over 80,000 women found that urodynamic testing can establish the diag-
nosis of urodynamic stress urinary incontinence but it cannot predict the outcome of surgical 
treatment [37]. A detailed account of commonly performed urodynamic testing is given below:
2.3.2.1. Uroflowmetry
Uroflowmetry provides a non-invasive easy to perform test to assess the dynamics of urinary 
flow. The amount of information provided by UFM, along with ultrasonic estimation of resid-
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ual urine in the bladder, usually is enough in the routine evaluation of elderly men with lower 
urinary tract symptoms (LUTS). It is one of the most common performed urodynamic studies. 
The common clinical parameters used to assess the flow dynamics include maximum flow 
rate (Qmax) and flow pattern [38]. The diagnostic accuracy of uroflowmetry for detecting BPO 
is variable and is substantially influenced by threshold values. A threshold Qmax of 10 mL/s 
has a specificity of 70%, a PPV of 70% and a sensitivity of 47% for BOO. The specificity using 
a threshold Qmax of 15 mL/s was 38%, the PPV 67% and the sensitivity 82% [39].The main 
limitation of UFM is its inability to discriminate between poor detrusor function and bladder 
outlet obstruction (BOO), for which pressure flow studies are necessary.
2.3.2.2. Filling and voiding cystometry
Table 2 summarizes the indications for urodynamic studies comprising of filling and voiding 
cystometry.
2.3.2.3. Ambulatory and videourodynamics
Ambulatory and videourodynamics are indicated only if the diagnosis is unclear after con-
ventional urodynamics [40].
2.3.3. MRI Pelvic floor ultrasound and EMG
Imaging improves our understanding of the anatomical and functional abnormalities that 
may cause UI. In clinical research, MRI and EMG are used to evaluate urethral support in 
cases of SUI. There is a general consensus that MRI provides good global pelvic floor assess-
ment, including POP, defecatory function and integrity of the pelvic floor support [32]. 
However, it is not considered useful in the evaluation of UI [33]. Ultrasound imaging can 
reliably be used to measure bladder neck and urethral mobility in cases of SUI but it is not 
routinely performed in the initial assessment of UI.
3. Conclusions
Urinary incontinence is of various types, and its initial assessment requires detailed history 
taking and clinical examination. Since the disease has major impact on patient’s quality of 
Severe stress incontinence, previous pelvic radiation, previous anti-incontinence surgery
Overactive bladder not responding to conservative therapy
UI with voiding dysfunction
Voiding difficulty associated with UI and POP
Poorly definable or inconclusive history to support UI
Associated with diseases, which can affect the function of LUT/pelvic floor, e.g. diabetes mellitus, Parkinson’s disease, 
cerebrovascular accident and prolapsed intervertebral disc
Table 2. Indications for urodynamic studies.
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life hence the evaluation should lead to establish types of UI. Very few patients need invasive 
testing and usually urine analysis, culture, bladder diary, stress test are enough for initial 
assessment. Patients with neurogenic bladder and overactive bladder syndrome need specific 
testing for final diagnosis.
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